Stimuli-Responsive Drug Delivery Systems for Osteoarthritis Treatment

Osteoarthritis is a degenerative joint disease marked by cartilage breakdown, inflammation and pain. Conventional intra-articular injections suffer from rapid drug clearance and non-specific diffusion, necessitating frequent administrations and risking systemic side effects. Stimuli-responsive delivery systems harness changes in the joint microenvironment—such as pH shifts, oxidative stress, enzyme expression or temperature—to trigger controlled release of therapeutic agents. Engineered hydrogels, nanoparticles and nanoassemblies can be designed to respond to specific biochemical or physical cues, thereby improving localisation, prolonging residence time and enhancing payload stability. Examples include pH-sensitive metal–organic frameworks that release anti-inflammatory compounds in acidic synovial fluid; enzyme-degradable microspheres that liberate microRNA cargos under elevated matrix metalloproteinase activity; redox-responsive nanozymes that scavenge reactive oxygen species and release growth factors; and thermo-sensitive gels that transition in situ at physiological temperature. By combining targeting ligands, biofunctional scaffolds and stimulus-triggered kinetics, these systems aim to modulate local inflammation, promote chondrocyte viability and foster cartilage regeneration. Their development holds promise for reducing dosing frequency, improving patient comfort and achieving precision therapy in an ageing population.

Research from Nature Portfolio

Researchers have developed an injectable hydrogel composed of gallic acid-grafted gelatin, into which teriparatide-loaded liposomes are anchored. Upon intra-articular injection, the formulation rapidly gels in situ without impeding joint movement, and provides sustained release of the therapeutic peptide. In vitro studies demonstrated that the hydrogel promotes chondrocyte proliferation and protects against cytokine-induced degeneration through modulation of the PI3K/AKT signalling pathway. In osteoarthritic mouse models, this system enhanced glycosaminoglycan synthesis, attenuated cartilage erosion and reduced inflammatory markers, illustrating its potential as a minimally invasive, stimulus-responsive platform for cartilage repair.

Stimuli-Responsive Drug Delivery Systems for Osteoarthritis Treatment publication trend

The graph below shows the total number of articles in stimuli-responsive drug delivery systems for osteoarthritis treatment across all publications each year (not limited to Nature Index journals).

Technical terms

Stimuli-responsive: Materials engineered to change behaviour or release cargo in response to specific environmental triggers such as pH, enzymes, temperature or redox conditions.

Hydrogel: A water-swollen polymer network capable of encapsulating drugs and forming in situ depots within tissue.

Nanozyme: Nanomaterials with intrinsic enzyme-like catalytic activities used to modulate oxidative stress.

Matrix metalloproteinases (MMPs): A family of proteolytic enzymes upregulated in osteoarthritic joints that degrade cartilage extracellular matrix.

Reactive oxygen species (ROS): Chemically reactive molecules derived from oxygen that contribute to inflammation and tissue damage in osteoarthritis.

Liposome: A spherical vesicle composed of lipid bilayers, used to encapsulate and protect therapeutic agents for controlled release.

References

1. An injectable liposome-anchored teriparatide incorporated gallic acid-grafted gelatin hydrogel for osteoarthritis treatment. Nature Communications (2023).
2. pH-responsive and hyaluronic acid-functionalized metal–organic frameworks for therapy of osteoarthritis. Journal of Nanobiotechnology (2020).
3. Injectable “nano-micron” combined gene-hydrogel microspheres for local treatment of osteoarthritis. NPG Asia Materials (2022).
4. Using Cu‐Based Metal–Organic Framework as a Comprehensive and Powerful Antioxidant Nanozyme for Efficient Osteoarthritis Treatment. Advanced Science (2024).
5. Multifunctional thermo-sensitive hydrogel for modulating the microenvironment in Osteoarthritis by polarizing macrophages and scavenging RONS. Journal of Nanobiotechnology (2022).